Similar articles

• Reply to 'Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma'.

  Amaral T, Garbe C. Amaral T, et al. Expert Opin Pharmacother. 2017 Oct;18(14):1537. doi: 10.1080/14656566.2017.1367596. Epub 2017 Aug 18. Expert Opin Pharmacother. 2017. PMID: 28812387 No abstract available.
• [Development of targeted treatments for cutaneous T cell lymphomas].

  Bagot M. Bagot M. Bull Acad Natl Med. 2012 Mar;196(3):631-40; discussion 640-1, 653-4. Bull Acad Natl Med. 2012. PMID: 23472352 Review. French.
• Recent advances in the management of cutaneous lymphomas.

  Belloni B, Johansen N, Glass LF, Dummer R. Belloni B, et al. Semin Oncol. 2012 Apr;39(2):150-62. doi: 10.1053/j.seminoncol.2012.01.010. Semin Oncol. 2012. PMID: 22484187 Review.
• Therapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides.

  Lo Sicco K, Latkowski JA. Lo Sicco K, et al. J Drugs Dermatol. 2015 Dec;14(12):1381-3. J Drugs Dermatol. 2015. PMID: 26659928 Review. No abstract available.
• Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis.

  Lester L, Ewalt M, Warnke R, Kim J. Lester L, et al. J Cutan Pathol. 2015 Jan;42(1):46-9. doi: 10.1111/cup.12436. Epub 2014 Dec 9. J Cutan Pathol. 2015. PMID: 25384366